Item talk:Q331763
From geokb
{
"OpenAlex": {
"associated_institutions": [
{
"id": "https://openalex.org/I4210137003",
"ror": "https://ror.org/03c09ma81",
"display_name": "Bristol-Myers Squibb (Belgium)",
"country_code": "BE",
"type": "company",
"relationship": "child"
},
{
"id": "https://openalex.org/I4210110605",
"ror": "https://ror.org/01r00g076",
"display_name": "Bristol-Myers Squibb (Canada)",
"country_code": "CA",
"type": "company",
"relationship": "child"
},
{
"id": "https://openalex.org/I4210098725",
"ror": "https://ror.org/013b57229",
"display_name": "Bristol-Myers Squibb (France)",
"country_code": "FR",
"type": "company",
"relationship": "child"
},
{
"id": "https://openalex.org/I157075465",
"ror": "https://ror.org/032hfv632",
"display_name": "Bristol-Myers Squibb (Germany)",
"country_code": "DE",
"type": "company",
"relationship": "child"
},
{
"id": "https://openalex.org/I4210139887",
"ror": "https://ror.org/03zmqr331",
"display_name": "Bristol-Myers Squibb (India)",
"country_code": "IN",
"type": "company",
"relationship": "child"
},
{
"id": "https://openalex.org/I4210104917",
"ror": "https://ror.org/01h0vdv12",
"display_name": "Bristol-Myers Squibb (Ireland)",
"country_code": "IE",
"type": "company",
"relationship": "child"
},
{
"id": "https://openalex.org/I4210149313",
"ror": "https://ror.org/0433f0x41",
"display_name": "Bristol-Myers Squibb (Italy)",
"country_code": "IT",
"type": "company",
"relationship": "child"
},
{
"id": "https://openalex.org/I4210148404",
"ror": "https://ror.org/04dbmrm19",
"display_name": "Bristol-Myers Squibb (Japan)",
"country_code": "JP",
"type": "company",
"relationship": "child"
},
{
"id": "https://openalex.org/I4210087126",
"ror": "https://ror.org/00354aw77",
"display_name": "Bristol-Myers Squibb (Netherlands)",
"country_code": "NL",
"type": "company",
"relationship": "child"
},
{
"id": "https://openalex.org/I4210151895",
"ror": "https://ror.org/05hzjar70",
"display_name": "Bristol-Myers Squibb (South Korea)",
"country_code": "KR",
"type": "company",
"relationship": "child"
},
{
"id": "https://openalex.org/I4210134011",
"ror": "https://ror.org/035hx4w46",
"display_name": "Bristol-Myers Squibb (Sweden)",
"country_code": "SE",
"type": "company",
"relationship": "child"
},
{
"id": "https://openalex.org/I47396830",
"ror": "https://ror.org/02xqc6638",
"display_name": "Bristol-Myers Squibb (Switzerland)",
"country_code": "CH",
"type": "company",
"relationship": "child"
},
{
"id": "https://openalex.org/I4210125795",
"ror": "https://ror.org/03emf1n04",
"display_name": "Bristol-Myers Squibb (United Kingdom)",
"country_code": "GB",
"type": "company",
"relationship": "child"
}
],
"cited_by_count": 870528,
"country_code": "US",
"counts_by_year": [
{
"year": 2024,
"works_count": 585,
"cited_by_count": 50338
},
{
"year": 2023,
"works_count": 1136,
"cited_by_count": 68898
},
{
"year": 2022,
"works_count": 1125,
"cited_by_count": 67863
},
{
"year": 2021,
"works_count": 1043,
"cited_by_count": 67811
},
{
"year": 2020,
"works_count": 979,
"cited_by_count": 60556
},
{
"year": 2019,
"works_count": 774,
"cited_by_count": 51507
},
{
"year": 2018,
"works_count": 738,
"cited_by_count": 47131
},
{
"year": 2017,
"works_count": 818,
"cited_by_count": 44119
},
{
"year": 2016,
"works_count": 767,
"cited_by_count": 41009
},
{
"year": 2015,
"works_count": 654,
"cited_by_count": 36939
},
{
"year": 2014,
"works_count": 623,
"cited_by_count": 32973
},
{
"year": 2013,
"works_count": 632,
"cited_by_count": 31445
},
{
"year": 2012,
"works_count": 551,
"cited_by_count": 27613
}
],
"created_date": "2022-02-02",
"display_name": "Bristol-Myers Squibb (United States)",
"display_name_acronyms": [
"BMS"
],
"display_name_alternatives": [],
"geo": {
"city": "New York",
"geonames_city_id": "5128581",
"region": null,
"country_code": "US",
"country": "United States",
"latitude": 40.71427,
"longitude": -74.00597
},
"homepage_url": "https://www.bms.com/",
"ids": {
"openalex": "https://openalex.org/I4210091812",
"ror": "https://ror.org/00gtmwv55",
"grid": "grid.419971.3",
"wikipedia": "https://en.wikipedia.org/wiki/Bristol%20Myers%20Squibb"
},
"image_thumbnail_url": "https://upload.wikimedia.org/wikipedia/commons/thumb/a/a6/Bristolmyersprincetonfacility.jpg/100px-Bristolmyersprincetonfacility.jpg",
"image_url": "https://upload.wikimedia.org/wikipedia/commons/a/a6/Bristolmyersprincetonfacility.jpg",
"international": {
"display_name": {
"en": "Bristol-Myers Squibb (United States)"
}
},
"is_super_system": false,
"lineage": [
"https://openalex.org/I4210091812"
],
"repositories": [],
"roles": [
{
"role": "institution",
"id": "https://openalex.org/I4210091812",
"works_count": 18834
},
{
"role": "funder",
"id": "https://openalex.org/F4320307115",
"works_count": 4876
}
],
"ror": "https://ror.org/00gtmwv55",
"summary_stats": {
"2yr_mean_citedness": 6.4880073800738005,
"h_index": 351,
"i10_index": 9305
},
"topic_share": [
{
"id": "https://openalex.org/T12255",
"display_name": "Immunogenicity of Biosimilar Therapeutics in Drug Development",
"value": 0.0075219,
"subfield": {
"id": "https://openalex.org/subfields/2403",
"display_name": "Immunology"
},
"field": {
"id": "https://openalex.org/fields/24",
"display_name": "Immunology and Microbiology"
},
"domain": {
"id": "https://openalex.org/domains/1",
"display_name": "Life Sciences"
}
},
{
"id": "https://openalex.org/T10158",
"display_name": "Cancer Immunotherapy",
"value": 0.0061911,
"subfield": {
"id": "https://openalex.org/subfields/2730",
"display_name": "Oncology"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T11491",
"display_name": "Chimeric Antigen Receptor T Cell Therapy",
"value": 0.0050741,
"subfield": {
"id": "https://openalex.org/subfields/2730",
"display_name": "Oncology"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T11124",
"display_name": "Protein Aggregation and Biopharmaceutical Stability",
"value": 0.0050276,
"subfield": {
"id": "https://openalex.org/subfields/1312",
"display_name": "Molecular Biology"
},
"field": {
"id": "https://openalex.org/fields/13",
"display_name": "Biochemistry, Genetics and Molecular Biology"
},
"domain": {
"id": "https://openalex.org/domains/1",
"display_name": "Life Sciences"
}
},
{
"id": "https://openalex.org/T10526",
"display_name": "Efficacy and Safety of Antiretroviral Therapy for HIV",
"value": 0.0044886,
"subfield": {
"id": "https://openalex.org/subfields/2725",
"display_name": "Infectious Diseases"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T12708",
"display_name": "Economic Burden of Cancer Treatment",
"value": 0.0039236,
"subfield": {
"id": "https://openalex.org/subfields/2002",
"display_name": "Economics and Econometrics"
},
"field": {
"id": "https://openalex.org/fields/20",
"display_name": "Economics, Econometrics and Finance"
},
"domain": {
"id": "https://openalex.org/domains/2",
"display_name": "Social Sciences"
}
},
{
"id": "https://openalex.org/T10649",
"display_name": "Diagnosis and Treatment of Multiple Myeloma",
"value": 0.0038048,
"subfield": {
"id": "https://openalex.org/subfields/2720",
"display_name": "Hematology"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T10256",
"display_name": "Drug Delivery Systems",
"value": 0.0036599,
"subfield": {
"id": "https://openalex.org/subfields/3003",
"display_name": "Pharmaceutical Science"
},
"field": {
"id": "https://openalex.org/fields/30",
"display_name": "Pharmacology, Toxicology and Pharmaceutics"
},
"domain": {
"id": "https://openalex.org/domains/1",
"display_name": "Life Sciences"
}
},
{
"id": "https://openalex.org/T11215",
"display_name": "Efficacy and Resistance in CML Treatment",
"value": 0.003462,
"subfield": {
"id": "https://openalex.org/subfields/2720",
"display_name": "Hematology"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T12534",
"display_name": "Targeted Protein Degradation in Biomedical Research",
"value": 0.0034484,
"subfield": {
"id": "https://openalex.org/subfields/1312",
"display_name": "Molecular Biology"
},
"field": {
"id": "https://openalex.org/fields/13",
"display_name": "Biochemistry, Genetics and Molecular Biology"
},
"domain": {
"id": "https://openalex.org/domains/1",
"display_name": "Life Sciences"
}
},
{
"id": "https://openalex.org/T11235",
"display_name": "Statistical Methods in Clinical Trials and Drug Development",
"value": 0.0033343,
"subfield": {
"id": "https://openalex.org/subfields/2613",
"display_name": "Statistics and Probability"
},
"field": {
"id": "https://openalex.org/fields/26",
"display_name": "Mathematics"
},
"domain": {
"id": "https://openalex.org/domains/3",
"display_name": "Physical Sciences"
}
},
{
"id": "https://openalex.org/T10375",
"display_name": "Drug Metabolism and Pharmacogenomics",
"value": 0.0031016,
"subfield": {
"id": "https://openalex.org/subfields/3004",
"display_name": "Pharmacology"
},
"field": {
"id": "https://openalex.org/fields/30",
"display_name": "Pharmacology, Toxicology and Pharmaceutics"
},
"domain": {
"id": "https://openalex.org/domains/1",
"display_name": "Life Sciences"
}
},
{
"id": "https://openalex.org/T11157",
"display_name": "Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia",
"value": 0.0025485,
"subfield": {
"id": "https://openalex.org/subfields/2716",
"display_name": "Genetics"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T10401",
"display_name": "Management of Diabetes Mellitus and Cardiovascular Risk",
"value": 0.0023591,
"subfield": {
"id": "https://openalex.org/subfields/2712",
"display_name": "Endocrinology, Diabetes and Metabolism"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T11533",
"display_name": "Mammalian MAP Kinase Signaling Pathways",
"value": 0.0022937,
"subfield": {
"id": "https://openalex.org/subfields/1312",
"display_name": "Molecular Biology"
},
"field": {
"id": "https://openalex.org/fields/13",
"display_name": "Biochemistry, Genetics and Molecular Biology"
},
"domain": {
"id": "https://openalex.org/domains/1",
"display_name": "Life Sciences"
}
},
{
"id": "https://openalex.org/T12653",
"display_name": "Aryne Chemistry in Organic Synthesis",
"value": 0.0022282,
"subfield": {
"id": "https://openalex.org/subfields/1605",
"display_name": "Organic Chemistry"
},
"field": {
"id": "https://openalex.org/fields/16",
"display_name": "Chemistry"
},
"domain": {
"id": "https://openalex.org/domains/3",
"display_name": "Physical Sciences"
}
},
{
"id": "https://openalex.org/T10065",
"display_name": "Atrial Fibrillation",
"value": 0.0022155,
"subfield": {
"id": "https://openalex.org/subfields/2705",
"display_name": "Cardiology and Cardiovascular Medicine"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T10755",
"display_name": "HER2 Signaling in Breast Cancer Treatment",
"value": 0.0021423,
"subfield": {
"id": "https://openalex.org/subfields/2730",
"display_name": "Oncology"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T10151",
"display_name": "Hepatitis C Infection and Treatment",
"value": 0.0021369,
"subfield": {
"id": "https://openalex.org/subfields/2721",
"display_name": "Hepatology"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T11016",
"display_name": "Therapeutic Antibodies: Development, Engineering, and Applications",
"value": 0.0021209,
"subfield": {
"id": "https://openalex.org/subfields/2741",
"display_name": "Radiology, Nuclear Medicine and Imaging"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T10570",
"display_name": "Mechanisms of Multidrug Resistance in Cancer",
"value": 0.0020618,
"subfield": {
"id": "https://openalex.org/subfields/2730",
"display_name": "Oncology"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T12318",
"display_name": "Chemistry and Pharmacology of Quinazoline Compounds",
"value": 0.0019702,
"subfield": {
"id": "https://openalex.org/subfields/1605",
"display_name": "Organic Chemistry"
},
"field": {
"id": "https://openalex.org/fields/16",
"display_name": "Chemistry"
},
"domain": {
"id": "https://openalex.org/domains/3",
"display_name": "Physical Sciences"
}
},
{
"id": "https://openalex.org/T13489",
"display_name": "Synthesis and Applications of \u00df-Lactams",
"value": 0.0019604,
"subfield": {
"id": "https://openalex.org/subfields/1605",
"display_name": "Organic Chemistry"
},
"field": {
"id": "https://openalex.org/fields/16",
"display_name": "Chemistry"
},
"domain": {
"id": "https://openalex.org/domains/3",
"display_name": "Physical Sciences"
}
},
{
"id": "https://openalex.org/T13649",
"display_name": "Amide Chemistry and Synthesis",
"value": 0.0019268,
"subfield": {
"id": "https://openalex.org/subfields/1605",
"display_name": "Organic Chemistry"
},
"field": {
"id": "https://openalex.org/fields/16",
"display_name": "Chemistry"
},
"domain": {
"id": "https://openalex.org/domains/3",
"display_name": "Physical Sciences"
}
},
{
"id": "https://openalex.org/T11067",
"display_name": "Advancements in Colorectal Cancer Research",
"value": 0.0019254,
"subfield": {
"id": "https://openalex.org/subfields/2730",
"display_name": "Oncology"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
}
],
"topics": [
{
"id": "https://openalex.org/T10158",
"display_name": "Cancer Immunotherapy",
"count": 1391,
"subfield": {
"id": "https://openalex.org/subfields/2730",
"display_name": "Oncology"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T11016",
"display_name": "Therapeutic Antibodies: Development, Engineering, and Applications",
"count": 1008,
"subfield": {
"id": "https://openalex.org/subfields/2741",
"display_name": "Radiology, Nuclear Medicine and Imaging"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T11491",
"display_name": "Chimeric Antigen Receptor T Cell Therapy",
"count": 858,
"subfield": {
"id": "https://openalex.org/subfields/2730",
"display_name": "Oncology"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T10526",
"display_name": "Efficacy and Safety of Antiretroviral Therapy for HIV",
"count": 812,
"subfield": {
"id": "https://openalex.org/subfields/2725",
"display_name": "Infectious Diseases"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T10911",
"display_name": "Peptide Synthesis and Drug Discovery",
"count": 674,
"subfield": {
"id": "https://openalex.org/subfields/1312",
"display_name": "Molecular Biology"
},
"field": {
"id": "https://openalex.org/fields/13",
"display_name": "Biochemistry, Genetics and Molecular Biology"
},
"domain": {
"id": "https://openalex.org/domains/1",
"display_name": "Life Sciences"
}
},
{
"id": "https://openalex.org/T10804",
"display_name": "Health Economics and Quality of Life Assessment",
"count": 659,
"subfield": {
"id": "https://openalex.org/subfields/2002",
"display_name": "Economics and Econometrics"
},
"field": {
"id": "https://openalex.org/fields/20",
"display_name": "Economics, Econometrics and Finance"
},
"domain": {
"id": "https://openalex.org/domains/2",
"display_name": "Social Sciences"
}
},
{
"id": "https://openalex.org/T10908",
"display_name": "Chiral Separation in Chromatography",
"count": 650,
"subfield": {
"id": "https://openalex.org/subfields/1607",
"display_name": "Spectroscopy"
},
"field": {
"id": "https://openalex.org/fields/16",
"display_name": "Chemistry"
},
"domain": {
"id": "https://openalex.org/domains/3",
"display_name": "Physical Sciences"
}
},
{
"id": "https://openalex.org/T11157",
"display_name": "Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia",
"count": 648,
"subfield": {
"id": "https://openalex.org/subfields/2716",
"display_name": "Genetics"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T11124",
"display_name": "Protein Aggregation and Biopharmaceutical Stability",
"count": 640,
"subfield": {
"id": "https://openalex.org/subfields/1312",
"display_name": "Molecular Biology"
},
"field": {
"id": "https://openalex.org/fields/13",
"display_name": "Biochemistry, Genetics and Molecular Biology"
},
"domain": {
"id": "https://openalex.org/domains/1",
"display_name": "Life Sciences"
}
},
{
"id": "https://openalex.org/T10065",
"display_name": "Atrial Fibrillation",
"count": 566,
"subfield": {
"id": "https://openalex.org/subfields/2705",
"display_name": "Cardiology and Cardiovascular Medicine"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T12255",
"display_name": "Immunogenicity of Biosimilar Therapeutics in Drug Development",
"count": 554,
"subfield": {
"id": "https://openalex.org/subfields/2403",
"display_name": "Immunology"
},
"field": {
"id": "https://openalex.org/fields/24",
"display_name": "Immunology and Microbiology"
},
"domain": {
"id": "https://openalex.org/domains/1",
"display_name": "Life Sciences"
}
},
{
"id": "https://openalex.org/T10151",
"display_name": "Hepatitis C Infection and Treatment",
"count": 551,
"subfield": {
"id": "https://openalex.org/subfields/2721",
"display_name": "Hepatology"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T10211",
"display_name": "Computational Methods in Drug Discovery",
"count": 522,
"subfield": {
"id": "https://openalex.org/subfields/1703",
"display_name": "Computational Theory and Mathematics"
},
"field": {
"id": "https://openalex.org/fields/17",
"display_name": "Computer Science"
},
"domain": {
"id": "https://openalex.org/domains/3",
"display_name": "Physical Sciences"
}
},
{
"id": "https://openalex.org/T10580",
"display_name": "Immunobiology of Dendritic Cells",
"count": 518,
"subfield": {
"id": "https://openalex.org/subfields/2403",
"display_name": "Immunology"
},
"field": {
"id": "https://openalex.org/fields/24",
"display_name": "Immunology and Microbiology"
},
"domain": {
"id": "https://openalex.org/domains/1",
"display_name": "Life Sciences"
}
},
{
"id": "https://openalex.org/T10375",
"display_name": "Drug Metabolism and Pharmacogenomics",
"count": 496,
"subfield": {
"id": "https://openalex.org/subfields/3004",
"display_name": "Pharmacology"
},
"field": {
"id": "https://openalex.org/fields/30",
"display_name": "Pharmacology, Toxicology and Pharmaceutics"
},
"domain": {
"id": "https://openalex.org/domains/1",
"display_name": "Life Sciences"
}
},
{
"id": "https://openalex.org/T10417",
"display_name": "Advancements in Lung Cancer Research",
"count": 493,
"subfield": {
"id": "https://openalex.org/subfields/2740",
"display_name": "Pulmonary and Respiratory Medicine"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T11752",
"display_name": "Chemotherapy-Induced Peripheral Neuropathy in Cancer Treatment",
"count": 476,
"subfield": {
"id": "https://openalex.org/subfields/2730",
"display_name": "Oncology"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T10649",
"display_name": "Diagnosis and Treatment of Multiple Myeloma",
"count": 469,
"subfield": {
"id": "https://openalex.org/subfields/2720",
"display_name": "Hematology"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T11215",
"display_name": "Efficacy and Resistance in CML Treatment",
"count": 467,
"subfield": {
"id": "https://openalex.org/subfields/2720",
"display_name": "Hematology"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T11020",
"display_name": "Natural Killer Cells in Immunity",
"count": 457,
"subfield": {
"id": "https://openalex.org/subfields/2403",
"display_name": "Immunology"
},
"field": {
"id": "https://openalex.org/fields/24",
"display_name": "Immunology and Microbiology"
},
"domain": {
"id": "https://openalex.org/domains/1",
"display_name": "Life Sciences"
}
},
{
"id": "https://openalex.org/T10570",
"display_name": "Mechanisms of Multidrug Resistance in Cancer",
"count": 437,
"subfield": {
"id": "https://openalex.org/subfields/2730",
"display_name": "Oncology"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T12505",
"display_name": "Role of Fibroblast Activation in Cancer Progression",
"count": 429,
"subfield": {
"id": "https://openalex.org/subfields/2730",
"display_name": "Oncology"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T10401",
"display_name": "Management of Diabetes Mellitus and Cardiovascular Risk",
"count": 427,
"subfield": {
"id": "https://openalex.org/subfields/2712",
"display_name": "Endocrinology, Diabetes and Metabolism"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T10112",
"display_name": "Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome",
"count": 402,
"subfield": {
"id": "https://openalex.org/subfields/2406",
"display_name": "Virology"
},
"field": {
"id": "https://openalex.org/fields/24",
"display_name": "Immunology and Microbiology"
},
"domain": {
"id": "https://openalex.org/domains/1",
"display_name": "Life Sciences"
}
},
{
"id": "https://openalex.org/T10031",
"display_name": "Regulatory T Cell Development and Function",
"count": 387,
"subfield": {
"id": "https://openalex.org/subfields/2403",
"display_name": "Immunology"
},
"field": {
"id": "https://openalex.org/fields/24",
"display_name": "Immunology and Microbiology"
},
"domain": {
"id": "https://openalex.org/domains/1",
"display_name": "Life Sciences"
}
}
],
"type": "company",
"type_id": "https://openalex.org/institution-types/company",
"updated_date": "2024-09-04T17:12:26.605656",
"works_api_url": "https://api.openalex.org/works?filter=institutions.id:I4210091812",
"works_count": 18834,
"x_concepts": [
{
"id": "https://openalex.org/C86803240",
"wikidata": "https://www.wikidata.org/wiki/Q420",
"display_name": "Biology",
"level": 0,
"score": 88.3
},
{
"id": "https://openalex.org/C71924100",
"wikidata": "https://www.wikidata.org/wiki/Q11190",
"display_name": "Medicine",
"level": 0,
"score": 79.8
},
{
"id": "https://openalex.org/C185592680",
"wikidata": "https://www.wikidata.org/wiki/Q2329",
"display_name": "Chemistry",
"level": 0,
"score": 70.0
},
{
"id": "https://openalex.org/C126322002",
"wikidata": "https://www.wikidata.org/wiki/Q11180",
"display_name": "Internal medicine",
"level": 1,
"score": 66.3
},
{
"id": "https://openalex.org/C54355233",
"wikidata": "https://www.wikidata.org/wiki/Q7162",
"display_name": "Genetics",
"level": 1,
"score": 62.9
},
{
"id": "https://openalex.org/C55493867",
"wikidata": "https://www.wikidata.org/wiki/Q7094",
"display_name": "Biochemistry",
"level": 1,
"score": 56.1
},
{
"id": "https://openalex.org/C203014093",
"wikidata": "https://www.wikidata.org/wiki/Q101929",
"display_name": "Immunology",
"level": 1,
"score": 36.7
},
{
"id": "https://openalex.org/C178790620",
"wikidata": "https://www.wikidata.org/wiki/Q11351",
"display_name": "Organic chemistry",
"level": 1,
"score": 35.9
},
{
"id": "https://openalex.org/C142724271",
"wikidata": "https://www.wikidata.org/wiki/Q7208",
"display_name": "Pathology",
"level": 1,
"score": 33.9
},
{
"id": "https://openalex.org/C121332964",
"wikidata": "https://www.wikidata.org/wiki/Q413",
"display_name": "Physics",
"level": 0,
"score": 31.6
},
{
"id": "https://openalex.org/C98274493",
"wikidata": "https://www.wikidata.org/wiki/Q128406",
"display_name": "Pharmacology",
"level": 1,
"score": 28.3
},
{
"id": "https://openalex.org/C141071460",
"wikidata": "https://www.wikidata.org/wiki/Q40821",
"display_name": "Surgery",
"level": 1,
"score": 24.1
},
{
"id": "https://openalex.org/C15744967",
"wikidata": "https://www.wikidata.org/wiki/Q9418",
"display_name": "Psychology",
"level": 0,
"score": 22.3
},
{
"id": "https://openalex.org/C134018914",
"wikidata": "https://www.wikidata.org/wiki/Q162606",
"display_name": "Endocrinology",
"level": 1,
"score": 21.1
},
{
"id": "https://openalex.org/C60644358",
"wikidata": "https://www.wikidata.org/wiki/Q128570",
"display_name": "Bioinformatics",
"level": 1,
"score": 20.8
}
],
"id": "https://openalex.org/I4210091812"
}
}
